In the last trading session, 1.02 million shares of the Vaxart Inc (NASDAQ:VXRT) were traded, and its beta was 0.82. Most recently the company’s share price was $0.74, and it changed around $0.0 or -0.20% from the last close, which brings the market valuation of the company to $168.34M. VXRT currently trades at a discount to its 52-week high of $1.54, offering almost -108.11% off that amount. The share price’s 52-week low was $0.52, which indicates that the current value has risen by an impressive 29.73% since then. We note from Vaxart Inc’s average daily trading volume that its 10-day average is 2.61 million shares, with the 3-month average coming to 1.78 million.
Vaxart Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended VXRT as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight. Vaxart Inc is expected to report earnings per share of -0.11 for the current quarter.
Vaxart Inc (NASDAQ:VXRT) trade information
Instantly VXRT has showed a red trend with a performance of -0.20% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.8300 on recent trading dayincreased the stock’s daily price by 10.84%. The company’s shares are currently up 11.77% year-to-date, but still down -6.31% over the last five days. On the other hand, Vaxart Inc (NASDAQ:VXRT) is 26.52% up in the 30-day period. We can see from the shorts that 11.27 million shares have been sold at a short interest cover period of 11.71 day(s).
The consensus price target as assigned by Wall Street analysts is $2, which translates to bulls needing to increase their stock price by 63.0% from its current value. Analyst projections state that VXRT is forecast to be at a low of $2 and a high of $2.
Vaxart Inc (VXRT) estimates and forecasts
Vaxart Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 8.25 percent over the past six months and at a 31.58% annual growth rate that is well above the industry average of 16.60%. The year-over-year growth rate is expected to be 364.83%, up from the previous year.
Consensus estimates provided by 4 financial analysts predict the company will bring in an average of 15.68M in revenue for the current quarter. 3 analysts expect Vaxart Inc to make 8.33M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 3.25M and 2.18M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 383.05%. Forecasts for the next quarter put sales growth at 282.09%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 27.81%.
VXRT Dividends
Vaxart Inc’s next quarterly earnings report is expected to be released in February.
Vaxart Inc (NASDAQ:VXRT)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.87% of Vaxart Inc shares, and 17.80% of them are in the hands of institutional investors. The stock currently has a share float of 17.96%. Vaxart Inc stock is held by 119.0 institutions, with HERITAGE WEALTH ADVISORS being the largest institutional investor. By 2024-06-30, it held 9.5756% of the shares, which is about 21780.0 shares worth $14534.0.
SIO CAPITAL MANAGEMENT, LLC, with 8.7465% or 14.76 million shares worth $9.85 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Sep 30, 2024 . The former held 7.16 shares worth $5.3 million, making up 3.15% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 2.52 shares worth around $1.87 million, which represents about 1.11% of the total shares outstanding.
